TrialCardiovascular diabetology2017

Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis.

Michael Pfeifer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.